Project BioShield, the federal reserve fund created by Congress in 2004 to establish a $5.6 billion market for the development and production of drugs that could bioterror threats, has about $4.1 billion left to spend as of one year ago, according to a new report on the program prepared by the Department of Health and Human Services (HHS). So far, $1.9 billion remains to be spent from fiscal year 2004 through 2008 appropriations and another $2.2 billion is available between…
Recommended
Trending
Congress Updates
House Sends Dec. 11 CR With Ship Construction Funds To Trump’s Desk For Final Signature
The House on Tuesday passed a stopgap funding bill to keep the government open through Dec. 11, sending the temporary funding measure that also includes funds to support ongoing shipbuilding […]
Guetlein On Golden Dome: ‘We Cannot Protect This Nation And Bankrupt It At The Same Time’
While there has been criticism among missile defense advocates of Golden Dome’s development pace after the signing of an executive order in January last year, Space Force Gen. Michael Guetlein, […]
Interview with Rep. Jeff Crank (R-Colo.), co-chair of the Golden Dome Caucus
Rep. Jeff Crank (R-Colo.), a co-chair of the Golden Dome Caucus in Congress and a member of the House Armed Services Committee’s strategic forces panel, discusses the transformative defense investments […]
Space Force PAE For Infrastructure Completing Move To Colorado Springs
U.S. Space Force Space Systems Command’s (SSC) Portfolio Acquisition Executive (PAE) for infrastructure–a $4 billion contracting hub for SSC–is completing a move from Los Angeles Air Force Base, Calif. to […]